产品中心 药物靶点和Fc受体 药物靶点

所有图片(1/1)

LILRB4/CD85k/ILT3 mFc Chimera Protein, Cynomolgus

Leukocyte immunoglobulin (Ig)-like receptor B4,LILRB4,CD85K,ILT3

价格 3,100.00 供应商现货 : 3-5个工作日
货号 UA010079
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Cynomolgus
  • 分子别名

    Leukocyte immunoglobulin (Ig)-like receptor B4,LILRB4,CD85K,ILT3
  • 表达序列

    Gln22-Glu259, with C-terminal Mouse IgG2a Fc
  • 表达宿主

    HEK293
  • 分子量

    57-74kDa (Reducing)
  • 纯度

    >95% by SDS-PAGE
  • 内毒素含量

    <0.1EU/μg
  • 标记

    Unconjugated
  • 标签

    Mouse Fc Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4
  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
背景介绍
  • Leukocyte immunoglobulin (Ig)-like receptor B4 (LILRB4) is a member of leukocyte Ig-like receptors (LILRs). LILRB4 is encoded in the leukocyte receptor cluster, which is on human chromosome 19q13.4. The structure and function of LILRs are similar to those of other leukocyte receptor cluster receptors, such as killer cell immunoglobulin-like receptors. Leukocyte immunoglobulin-like receptor (LILRB4) is a kind of inhibitory receptor that plays a key role in immune checkpoint pathways. Inhibitory receptors also participate in achieving balance between activating and inhibitory actions to ensure immune responses to pathogens in the immune system. However, they not only protect the host from autoimmune responses, but also preserve peripheral tolerance. LILRB4 also regulates immune responses, and its role in regulating immune responses is mostly controlled by its ligands.
  • 电泳

    • 1μg(R: reducing conditions, N: non-reducing conditions).

评论(0)